Ibnsina Pharma Income Statement

Financials in millions EGP. Fiscal year is January - December.

Millions EGP. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	76,597	55,842	33,949	22,264	21,733
Revenue Growth (YoY)	37.17%	64.49%	52.48%	2.45%	16.35%
Cost of Revenue	70,148	51,446	31,434	20,648	20,103
Gross Profit	6,449	4,397	2,515	1,617	1,630
Selling, General & Admin	2,681	1,931	1,289	1,076	829.22
Amortization of Goodwill & Intangibles	-	-	-	-	2.75
Other Operating Expenses	-10.93	-7.39	-9.46	-7	-
Operating Expenses	2,907	2,139	1,364	1,135	962.17
Operating Income	3,542	2,258	1,152	482.22	667.35
Interest Expense	-2,559	-1,686	-1,044	-477.09	-284.18
Interest & Investment Income	0.18	0.2	-	-	-
Currency Exchange Gain (Loss)	4.67	55.35	38.53	38.41	0.28
Other Non Operating Income (Expenses)	17.49	71.67	121.65	131.01	86.01
EBT Excluding Unusual Items	1,006	698.45	267.75	174.55	469.46
Gain (Loss) on Sale of Investments	-	1.88	-1.13	-	-
Gain (Loss) on Sale of Assets	71.51	2.95	1.39	0.75	4.25
Legal Settlements	-	-	-	-	-48
Other Unusual Items	-	-	-	-	-0.37
Pretax Income	1,077	703.28	268.02	175.31	425.34
Income Tax Expense	125.36	88.72	54.74	4.43	110.95
Earnings From Continuing Operations	951.98	614.56	213.27	170.87	314.4
Minority Interest in Earnings	-0	0	0.39	1.71	0.33
Net Income	951.98	614.56	213.66	172.58	314.73
Preferred Dividends & Other Adjustments	180.88	116.77	40.52	36.95	28.4
Net Income to Common	771.11	497.8	173.14	135.63	286.33
Net Income Growth	54.90%	187.63%	23.80%	-45.16%	40.09%
Shares Outstanding (Basic)	1,008	1,008	1,008	1,008	1,302
Shares Outstanding (Diluted)	1,008	1,008	1,008	1,008	1,302
Shares Change (YoY)	-	-	-	-22.58%	16.25%
EPS (Basic)	0.76	0.49	0.17	0.13	0.22
EPS (Diluted)	0.76	0.49	0.17	0.13	0.22
EPS Growth	54.90%	187.51%	27.65%	-38.81%	33.78%
Free Cash Flow	-805.66	-1,187	-228.23	-436.58	-487.96
Free Cash Flow Per Share	-0.80	-1.18	-0.23	-0.43	-0.38
Dividend Per Share	-	0.160	-	-	0.086
Gross Margin	8.42%	7.87%	7.41%	7.26%	7.50%
Operating Margin	4.62%	4.04%	3.39%	2.17%	3.07%
Profit Margin	1.01%	0.89%	0.51%	0.61%	1.32%
Free Cash Flow Margin	-1.05%	-2.13%	-0.67%	-1.96%	-2.25%
EBITDA	3,714	2,391	1,266	596.27	784.78
EBITDA Margin	4.85%	4.28%	3.73%	2.68%	3.61%
D&A For EBITDA	171.77	133.16	114.18	114.04	117.43
EBIT	3,542	2,258	1,152	482.22	667.35
EBIT Margin	4.62%	4.04%	3.39%	2.17%	3.07%
Effective Tax Rate	11.64%	12.62%	20.42%	2.53%	26.08%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.